# OnCo record eikon-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/eikon-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "eikon-therapeutics" ;
  schema:name "Eikon Therapeutics"@en ;
  schema:description "Eikon Therapeutics is a United States-based biotechnology company running 6 late-stage cancer trials of EIK1001, EIK1004-001 (IMP1707-001) and IMP1734 in melanoma, non-small-cell lung cancer and gastric & gastro-oesophageal junction cancer."@en ;
  schema:url <https://onco.cc/companies/eikon-therapeutics/>, <https://www.eikontx.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.eikontx.com>, <https://clinicaltrials.gov/search?lead=Eikon%20Therapeutics> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/endometrial/> ;
  onco:drugs <https://onco.cc/drugs/eik1001/>, <https://onco.cc/drugs/eik1005/>, <https://onco.cc/drugs/imp1734/> ;
  onco:companies <https://onco.cc/companies/lux-capital/> ;
  onco:trials <https://onco.cc/trials/nct06246110/>, <https://onco.cc/trials/nct06907043/> .